Bionovo   Report issue

For profit Phase 2 Phase 3
Founded: Emeryville California United States (2002)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2006
NCT00119665
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Bionovo Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

mf101 (5 trials)

Drugs in Phase 2 Trials (2)

bzl101 (2 trials)

vg101 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Breast Neoplasms (Phase 2)

Hot Flashes (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 3